Palisade Bio (PALI) Net Equity Issued and Repurchased (2009 - 2026)
Palisade Bio (PALI) recorded Net Equity Issued and Repurchased of $3.25 million in Q1 2026, down 97.4% from the prior quarter.
Powered by 
Analysis
Palisade Bio (PALI) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For FY2025, Palisade Bio reported Net Equity Issued and Repurchased of $128.22 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 155.6% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $8.44 million in FY2024 (-10.4%), $9.42 million in FY2023 (-34.6%), $14.4 million in FY2022 (+176.5%) and $5.21 million in FY2021 (+343.3%).
- Quarterly Net Equity Issued and Repurchased has ranged from $3,000 in Q2 2025 to $124.31 million in Q4 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at $124.31 million (Q4 2025), $3.91 million (Q3 2025) and $3,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Palisade Bio | 239.59 Mn | -265.23 Mn | - | 480.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 480.00 |
| Jun 30, 2026 | 175,000.00 |
| Mar 31, 2026 | 3.25 Mn |
| Dec 31, 2025 | 131.96 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Dec 31, 2024 | 4.44 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 5.50 Mn |
| Mar 31, 2023 | 4.94 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 12.63 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Dec 31, 2021 | 99,000.00 |
| Dec 31, 2020 | 1.18 Mn |
| Sep 30, 2020 | -14.70 Mn |
| Jun 30, 2020 | 7.97 Mn |
| Mar 31, 2020 | 6.73 Mn |
API Access
Palisade Bio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();